Borderline Resectable Pancreatic Cancer: What Have We Learned and Where Do We Go From Here?

被引:31
|
作者
Katz, Matthew H. G. [1 ]
Pisters, Peter W. T. [1 ]
Lee, Jeffrey E. [1 ]
Fleming, Jason B. [1 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Surg Oncol, Houston, TX 77030 USA
关键词
EXPERT CONSENSUS STATEMENT; ADENOCARCINOMA; DEFINITIONS; THERAPY;
D O I
10.1245/s10434-010-1460-y
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:608 / 610
页数:3
相关论文
共 50 条
  • [41] Solar fusion and the Coulomb dissociation of 8B -: What have we learned and where do we go from here?
    Gai, M
    ACTA PHYSICA HUNGARICA A-HEAVY ION PHYSICS, 2004, 21 (2-4): : 335 - 340
  • [42] Breastfeeding: What Do We Know, and Where Do We Go From Here?
    Furman, Lydia
    PEDIATRICS, 2017, 139 (04)
  • [43] Repatriation: what do we know and where do we go from here
    Chiang, Flora F. T.
    van Esch, Emmy
    Birtch, Thomas A.
    Shaffer, Margaret A.
    INTERNATIONAL JOURNAL OF HUMAN RESOURCE MANAGEMENT, 2018, 29 (01): : 188 - 226
  • [44] DEFLAGRATION - WHAT IS IT AND WHERE DO WE GO FROM HERE
    BRAY, AM
    TAPPI JOURNAL, 1989, 72 (12): : 251 - 253
  • [45] Now what? Where do we go from here?
    Mehta, Noshir
    CRANIO-THE JOURNAL OF CRANIOMANDIBULAR & SLEEP PRACTICE, 2021, 39 (01): : 4 - 4
  • [46] WHERE IS HERE AND WHERE DO WE GO FROM HERE
    MAHON, B
    ONLINE & CDROM REVIEW, 1994, 18 (01): : 45 - 45
  • [47] Researching European Union Agencies: What Have We Learnt (and Where Do We Go from Here)?
    Egeberg, Morten
    Trondal, Jarle
    JCMS-JOURNAL OF COMMON MARKET STUDIES, 2017, 55 (04) : 675 - 690
  • [48] Functional imaging of stroke recovery: what have we learnt and where do we go from here?
    Johansen-Berg, Heidi
    INTERNATIONAL JOURNAL OF STROKE, 2007, 2 (01) : 7 - 16
  • [49] Anti-tumor necrosis factor a therapy and heart failure - What have we learned and where do we go from here?
    Khanna, D
    McMahon, M
    Furst, DE
    ARTHRITIS AND RHEUMATISM, 2004, 50 (04): : 1040 - 1050
  • [50] Genetic basis of susceptibility to drug-induced liver injury: what have we learned and where do we go from here?
    Urban, Thomas J.
    Goldstein, David B.
    Watkins, Paul B.
    PHARMACOGENOMICS, 2012, 13 (07) : 735 - 738